Regulatory Issues for Bioaerosols

  • Philip Sayre
  • John Burckle
  • Gregory Macek
  • Gerald LaVeck


In broad terms, biotechnology is the harnessing of biological processes for the production of commercially useful substances. The basic concepts have been practiced for thousands of years, yielding many products used in commerce today. But the applications of biotechnology based on genetic engineering support a new industry with tremendous potential to develop even more useful products. An improved capability to address potential concerns posed by these products is needed. Commercial biotechnology applications can be divided into two loosely defined categories: (1) contained product manufacturing processes and (2) uncontained and semicontained processes.


Depth Filter Fermentor Exhaust Fermentation Plant Product Manufacturing Process Environmental Exposure Assessment 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Abbott, I. A., Bonball, J. L., G. Chester, T. B. Hart, G. J. Turnbull, et al. 1987. Worker exposure to a herbicide applied with ground sprayers in the United Kingdom. Amer. Ind. Hyg. Assoc. J. 48 (2): 167–175.CrossRefGoogle Scholar
  2. Batelle, 1988. Large–scale DNA Processing Facilities—Volume 2 of 4: Containment Technologies and Volume 4 of 4: Worker Exposure Modelling. Final Report (Sept, 1988) written under EPA Contract No. 68–03–3248. Batelle, Columbus, Ohio.Google Scholar
  3. Batelle, 1991. Support document for preparation of engineering assessments for genetically–engineered microorganisms. Final Report (October 31, 1991 ) written under EPA Contract No. 68–10–0003. Battelle, Columbus, Ohio.Google Scholar
  4. Blanchard, D. C., and L. D. Syzdek. 1982. Water-to-air transfer and enrichment of bacteria in drops from bursting bubbles. Appl. Environ. Microbiol. 43: 1001–1005.PubMedGoogle Scholar
  5. Bruno, C. F., and L. A. Szabo. 1983. Fermentation air filtration upgrading by use of membrane cartridge filters. Biotech. Bioeng. 25: 1223–1227.CrossRefGoogle Scholar
  6. CDC. 1974. Classification of etiological agents on the basis of hazard, 4th edi. CDC Office of Biosafety, Atlanta, GA.Google Scholar
  7. CDC & NIH. 1984. Biosafety in microbiological and biomedical laboratories, 1st ed. CDC and NIH, Atlanta, GA.Google Scholar
  8. CEB (Chemical Engineering Branch). 1991. Preparation of engineering assessments - Volume 1: CEB Engineering, Chemical Engineering Branch of the Economics, Exposure, and Technology Division, Office of Pollution Prevention and Toxics, U.S. EPA, Washington, DC.Google Scholar
  9. Conway, R. S. 1984. State of the art in fermentation air filtration. Biotech. Bioeng. 26: 844–847.CrossRefGoogle Scholar
  10. EPA. 1986. Policy statement 51 FR23313.Google Scholar
  11. EPA. 1987. Biotechnology model: Microbe–Screen. Contract # 68–02–4246), USEPA/ OTS/EED, Washington, DC.Google Scholar
  12. EPA (Office of Pesticides and Toxic Substances). 1991. Summary of the biotechnology Science advisory Committee’s subcommittee on the proposed TSCA Biotechnology Rule. USEPA/OPTS.Google Scholar
  13. EPA. 1992. Monitoring small-scale field tests of microorganisms. Office of Prevention, Pesticides, and Toxic Substances (EPA 700 R-92–008), Washington, DC.Google Scholar
  14. FDA. 199la. In Code of Federal Regulation, Title 21, parts 600–680. U.S. Government Printing Office, Washington, DC.Google Scholar
  15. FDA 199lb. In Code of Federal Regulations, Title 21, parts 200–211. U. S. Government Printing Office, Washington, DC.Google Scholar
  16. George, E., M. Kohan, D. Whitehouse, J. Creason, C. Kawanishi, R. Sherwood, and L. Claxton. 1991. Distribution, clearance, and mortality of environmental pseudomonads in mice upon intranasal exposure. Appl. Environ. Microbiol. 57 (8): 2420–2425.PubMedGoogle Scholar
  17. Hill, D., and M. Beatrice. 1989a. Biotechnology facility requirements, Part I: Facility and systems design. Biopharm, 20–25.Google Scholar
  18. Hill, D. and M. Beatrice. 1989b Biotechnology facility requirements, Part II: Operating procedures and validation. Biopharm 28–32.Google Scholar
  19. Karol, M., J. Stadler, and C. Magreni. 1985. Immunotoxicologic evaluation of the respiratory system: animal models for immediate-and delayed-onset pulmonary hypersensitivity. Funda. Appl. Toxicol. 5: 459–472.CrossRefGoogle Scholar
  20. Leahy, T. J., and F. R. Gabler. 1984. Sterile filtration of gases by membrane filters. Biotech. Bioeng. 26: 836–843.Google Scholar
  21. Maigetter, R., F. Bailey, and B. Miller. 1990. Safe handling of microganisms in small-and large-scale BL-3 fermentation facilities. Biopharm 22–29.Google Scholar
  22. Marsh, M. M. 1984. Attachment II, Recombinant DNA Advisory Committee Large-Scale Working Group, National Institutes of Health, Minutes of Feb. 7, 1984 meeting.Google Scholar
  23. Martinez, K., J. Sheehy, J. Jones, and L. Cusick. 1988. Microbial containment in conventional fermentation processes. J. Appl. Ind. Hyg. 3 (6): 177–181.Google Scholar
  24. McClung, G., and P. Sayre. 1993. Ecological risk assessment case study: Risk assessment for the release of recombinant rhizobia at small-scale agricultural field sites. Prepared for the Risk Assessment Forum, Office of Research and Development, U.S. EPA. (EPA 600/in press).Google Scholar
  25. Meltzer, T. H. 1987. Filtration in the pharmaceutical industry. Marcel Dekker, New York.Google Scholar
  26. Milewski, E. 1990. EPA Regulations covering release of genetically engineered microorganisms. Pp. 319–340. In J. Nakas and C. Hagedorn (eds.), Biotechnology of plant-microbe interactions, McGraw-Hill Publishing Co., New York.Google Scholar
  27. National Cancer Institute. 1974. National Cancer Institute safety standards for research involving oncogenic viruses. U.S. Government Printing Office, Washington, DC. [DHEW Publication No. (NIH) 75–790]Google Scholar
  28. NIH. 1986. Guidelines for the use of recombinant DNA molecules, Federal Register 51 (88): 16958–16985.Google Scholar
  29. NIH. 1991. Revision of the NIH guidelines subcommittee meeting Minutes from 15 Octoberr 1990 and 7 December 1990. Recombinant DNA Tech. Bull. 14 (4): 411–437.Google Scholar
  30. NIOSH, 1986a. In-depth survey report: Control technology assessment of enzyme fermentation processes. Assessment of enzyme fermentation processes at Gist-Brocades., USA, Inc. (Kingstree, S. Carolina). U.S. Department of Health and Human Services, National Institute for Occupational Safety and Health. U.S. Government Printing Office, Washington, DC. [DHHA (NIOSH) Publication No. ECTB 116–1b]Google Scholar
  31. NIOSH, 1986b. In-depth survey report: Control technology assessment of enzyme fermentation processes. Assessment of enzyme fermentation processes at Novo Biochemical Industries (Franklin, N. Carolina). U.S. Department of Health and Human Services, National Institute for Occupational Safety and Health. U.S. Government Printing Office, Washington, DC. [DHHA (NIOSH) Publication No. ECTB 116–15b.]Google Scholar
  32. NIOSH, 1986c. In-depth survey report: Control technology assessment of enzyme fermentation processes at Miles Laboratories (Elkhart, Indiana). U.S. Department of Health and Human Services, National Institute for Occupational Safety and Health. U.S.Google Scholar
  33. Government Printing Office, Washington, DC. [D1’-IHA (NIOSH) Publication No. ECTB 116–16b.]Google Scholar
  34. NIOSH, 1988. Control technology assessment of enzyme fermentation processes. U.S. Department of Health and Human Services, National Institute for Occupational Safety and Health. U.S. Government Printing Office, Washingtin, DC. [DHHA (NIOSH) Publication No. 88–114].Google Scholar
  35. OECD. 1986. Recombinant DNA safety considerations. OECD, Paris.Google Scholar
  36. OECD. 1991. Safety Considerations for the use of genetically modified organisms. OECD, Paris. [DSTI/STP(91)14]Google Scholar
  37. OSHA. 1992. CFR Part 1910. 1000. Table Z-1-A. Limits for Air Contaminants, p. 27.Google Scholar
  38. Office of Science and Technology Policy. 1986. Coordinated framework for regulation of biotechnology; Announcement of policy and notice for public comment. Federal Register 51: 23302–23393.Google Scholar
  39. OECD. 1991. Safety considerations for the use of genetically modified organisms, Part 1: Elaboration of criteria and principles for the good industrial large-scale practice. OECD, Paris.Google Scholar
  40. Plachak, R., R. Cohen, M. Ainslie, and C. Hoerner. 1988. Airborne endotoxin associated with industrial-scale production of protein products in gram-negative bacteria. Am. Indust. Hyg. Assoc. J. 49: 420–421.CrossRefGoogle Scholar
  41. Pall, D. B., and E. A. Kirnbauer. 1978. Bacterial removal prediction in membrane filters. 52nd Colloid and Surface Symposium held at the University of Tennessee, Knoxville, TN, June 1978.Google Scholar
  42. Reilly, B. 1991. Analysis of environmental releases and occupational exposure in support of proposed TSCA 5(h) (4) exemption. Draft EPA Report.Google Scholar
  43. Ritz, H., B. Evans, R. Bruce, E. Fletcher, G. Fisher, and K. Sarlo. (in press 1993) Fundamentals & Applied Toxicology. Respiratory and immunological responses of guinea pigs to enzyme-containing detergents: a comparison of intratracheal and inhalation modes of exposure. Fundamentals and App. Toxicol.Google Scholar
  44. Robertson, J. H., and W. R. Frieben. 1984. Microbial validation of vent filters. Biotech. Bioeng. 26: 825–835.Google Scholar
  45. Rubow, K. L. 1981. Submicron aerosol filtration characteristics of membrane filters. Ph. D. Thesis, University of Minnesota, Minneapolis.Google Scholar
  46. Sarlo, K., and E. Clark. 1992. A tier approach for evaluating the respiratory allergenicity of low molecular weight chemicals. Fund. Appl. Toxicol. 18: 107–114.CrossRefGoogle Scholar
  47. Sayre, P. 1990. Assessment of genetically engineered microorganisms under the Toxic Substances Control Act: Considerations prior to small-scale release. Pp. 405–414. In P. M. Gresshoff, L. E. Roth, G. Stacy, and W. E. Newton (eds.), Nitrogen fixation: Achievements and objectives. Chapman and Hall, New York.Google Scholar
  48. Sherwood, R., P. Thomas, C. Kawanishi, and J. Fenters. 1988. Comparison of Streptococcus zooepidemicus and influenza virus pathogenicity in mice by three pulmonary exposure routes. Appl. Environ. Microbiol. 54 (7): 1744–1751.PubMedGoogle Scholar
  49. Siegelbaum, H. 1991. Regulation through Consent Orders. Speech given at the EPA Conference “TSCA Section 5 and 8 Conference”. Washington, DC, 4–6 June.Google Scholar
  50. Turner, B. 1969. Workbook of atmospheric dispersion estimates. U.S. EPA/Research Triangle Park, NC. Public Health Service, Research Triangle Park, North Carolina.Google Scholar
  51. USDA. 1992. Guidelines recommended to USDA by the Agricultural Biotechnology Research Advisory Committee December 3–4, 1991. Document No. 91–04 available through the USDA Office of Agricultural Biotechnology.Google Scholar
  52. Wyza, R. B., and A. Leeson, 1991. Generation of bioaerosols in fermentation equipment and their control. Final report written under EPA Contract No. 68–10–0003, WA 010. Battelle, Columbus Division, Columbus, OH.Google Scholar

Copyright information

© Chapman & Hall, Inc. 1994

Authors and Affiliations

  • Philip Sayre
  • John Burckle
  • Gregory Macek
  • Gerald LaVeck

There are no affiliations available

Personalised recommendations